Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Efficacy and Safety of Simultaneous Integrated Boost (SIB-VMAT) Radiotherapy in HR/VHR Prostate Cancer With EPLNI

NCT07693075 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT07693075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07693075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Efficacy and Safety of Simultaneous Integrated Boost (SIB-VMAT) Radiotherapy in HR/VHR Prostate Cancer With EPLNI
Lead sponsor
Ain Shams University
Phase
Phase 2
Overall status
Recruiting
Start date
August 1, 2025
Completion date
November 1, 2026
Enrollment
30 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer patients treated by radiotherapy